Free Classifieds at USNetAds.com - View Item Content by ID 131892706

USNetAds > Health & Beauty > Health Services > Item ID 131892706

Item ID 131892706 in Category: Health & Beauty - Health Services

Cannot view this item. It could be pending, expired or deleted.
Below item is randomly selected from the same category and may have similar content.

Sofinnova’s New Biotech Fund Launches Three Startups


European life sciences investor Sofinnova Partners has closed its new biotechnology-focused fund, Biovelocita II, raising €165 million (over $180 million) to support emerging drugmakers. The fund has already launched at least three startups: U.K.-based Forth Therapeutics, French biotech Signadori Bio, and Italy’s BioClec, although the exact funding amounts for each startup were not disclosed.

Forth Therapeutics focuses on developing treatments for fibrosis, based on research from Neil Henderson’s lab at the University of Edinburgh. The company is also supported by the university’s venture fund, Old College Capital. Signadori Bio, originating from the Gustave Roussy oncology research center, will focus on developing cell therapies for cancer. Sofinnova partnered with Gustave Roussy in 2023 to identify research with potential for biotech startups, reviewing 50 projects so far. BioClec, co-founded by Washington University researcher Marco Colonna, aims to develop therapies for Alzheimer’s disease, drawing on Colonna’s research into innate immune mechanisms in neurodegeneration.

For more details please visit our website - https://www.medhealthinsight.com/sofinnovas-new-biotech-fund-launches-three-startups/


Related Link: Click here to visit item owner's website (0 hit)

Target State: New York
Target City : New York City
Last Update : Jun 30, 2025 3:25 AM
Number of Views: 28
Item  Owner  : medhealthinsight
Contact Email: (None)
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
USNetAds > Health & Beauty > Health Services > Item ID 131892706
 © 2025 USNetAds.com
2025-06-30 (0.598 sec)